• 0 Posts
  • 21 Comments
Joined 2 years ago
cake
Cake day: June 13th, 2023

help-circle


  • I think it is part of making government agencies ineffective to prove their ideology that these agencies should be abolished and replaced with private companies (or not at all). That way, they can say come election time, “See? Government can’t do these things well. We should eliminate these agencies.” Many people will forget they are also the reason the agencies are shitty.

    They have tried this with underfunding them in the past mostly. This is a much more direct approach.




  • Seriously. You aren’t really managing your employees if they have to organize resource shortages for you. At my job, I tell my colleagues to just take time off and, like me, list a few close co-workers as people to contact in case of emergencies in their OOO reply. Nothing is life-or-death, so people can deal with waiting. It’s not like anyone is taking off months straight.



  • Reading that article is a serious indictment of economic literacy in the United States. People don’t understand what role the president plays in the economy, what causes inflation, or how and why interest rates change. They draw really superficial causal links and don’t think about it after that; it’s fact to them.

    It’s reasons like this education may be the single most critical issue, since we can’t make progress on the climate or anything else if the population is incapable of critical thinking. I hate to say it like this because it feels patronizing, but Jesus fucking Christ.












  • Two points about R&D costs:

    First, they aren’t just trying to make up what they spent on this treatment, but others that failed during research/trials. There’s a lot of them the general public will never hear about, and pharmas generally don’t like to bring attention to their failures. Part of that is many shareholders are morons who don’t understand how science works.

    Second, the costs can get fuzzier for larger companies who in-house much of the R&D process, since the costs get shared among many programs. Properly attributing spend in that case can be a serious challenge.

    All that said, they’ve clearly seen an opportunity to rake it in with this trendy drug and are charging way more than they need to.